Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat ... 17 June, 2021
The Gregorio Marañón Hospital creates a spin-off to market the drug that protects the kidney ... 10 May, 2021
Six GENESIS Biomed clients feature in the 30 principal health science funding rounds in Catalonia ... 20 January, 2021
EIT Health Investors Network: a key opportunity for start-ups in search of funding ... 02 October, 2020
Aortyx, winner of Àlex Casta Awards to the best pitch of the Catalan Bioregion ... 29 September, 2020